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A total of 80 Candida isolates representing 14 species were examined for their respective responses to an in
vitro hemolytic test. A modification of a previously described plate assay system where the yeasts are incubated
on glucose (3%)-enriched sheep blood agar in a carbon dioxide (5%)-rich environment for 48 h was used to
evaluate the hemolytic activity. A group of eight Candida species which included Candida albicans (15 isolates),
C. dubliniensis (2), C. kefyr (2), C. krusei (4), C. zeylanoides (1), C. glabrata (34), C. tropicalis (5), and C. lusitaniae
(2) demonstrated both alpha and beta hemolysis at 48 h postinoculation. Only alpha hemolysis was detectable
in four Candida species, viz., C. famata (3), C. guilliermondii (4), C. rugosa (1), and C. utilis (1), while C. para-
psilosis (5) and C. pelliculosa (1) failed to demonstrate any hemolytic activity after incubation for 48 h or longer.
This is the first study to demonstrate the variable expression profiles of hemolysins by different Candida species.
Candida species have the ability to produce a variety of
hydrolytic enzymes, such as proteases, lipases, phospholipases,
esterases, and phosphatases (4, 11, 13). These enzymes have
received much attention in the past, as they are known to
mediate candidal pathogenesis, particularly by facilitating the
hyphal invasion especially seen in disseminated candidiasis (6).
While there have been a number of detailed studies on some of
these hydrolytic enzymes, such as proteases, lipases, and phos-
pholipases (8, 9, 14), little is known of the hemolytic activity
exhibited by different Candida species. Recently, Manns et al.
(10) described an elegant yet simple plate assay method for
observing the hemolytic activity of Candida albicans. We have
modified this method to evaluate the hemolytic activity of
different Candida species obtained from a variety of clinical
sources and to compare qualitatively and quantitatively the
species-specific differences in hemolysin production.
A total of 80 Candida isolates representing 14 different Can-
dida species obtained from clinical sources in different geo-
graphic locales were selected from strains deposited at the
Candida Culture Collection of the Oral Bio-Sciences Labora-
tory, Faculty of Dentistry, The University of Hong Kong, Hong
Kong (Table 1). For global comparison of data, a single refer-
ence laboratory strain each of C. albicans ATCC 90028, C. gla-
brata ATCC 2001, and C. parapsilosis ATCC 22019 (American
Type Culture Collection, Rockville, Md.) were also included.
The identity of all organisms was reconfirmed by the germ tube
test, and the commercially available API 20C Aux identifi-
cation kit (Analytical Profile Index; BioMerieux SA, Marcy
l’Etoile, France) (13). Stock cultures were maintained at
240°C. After recovery these were maintained on Sabouraud
dextrose agar (Oxoid Ltd, Basingstoke, Hampshire, England,
United Kingdom) and stored at 4 to 6°C during the experi-
mental period. Purity of cultures was ensured by regular ran-
dom identification of isolates by techniques described above.
In addition to the yeast strains, one strain each of Streptococcus
pyogenes (Lancefield group A) and Streptococcus sanguis,
which induce beta and alpha hemolysis, respectively, were used
as positive controls.
Hemolysin production was evaluated using a modification of
the plate assay described by Manns et al. (10). In brief, the
isolates were recovered from distilled water stored at 240°C. A
loopful of the stock culture was streaked onto Sabouraud dex-
trose agar and incubated at 37°C for 18 h. The resultant cul-
tures were harvested and washed with sterile saline, and a yeast
suspension with an inoculum size of 108 cells/ml was prepared
using hemocytometric counts (12). Ten microliters of this sus-
pension was spot inoculated on a sugar-enriched sheep blood
agar medium so as to yield a circular inoculation site of about
5 mm in diameter. The latter medium was prepared by adding
7 ml of fresh sheep blood (Hemostat, Dixon, Calif.) to 100 ml
of Sabouraud dextrose agar supplemented with 3% glucose
(final concentration, wt/vol; Merck, Darmstadt, Germany).
The final pH of the medium so prepared was 5.6 6 0.2. The
plates were incubated at 37°C in 5% CO2 for 48 h. The pres-
ence of a distinct translucent halo around the inoculum site,
viewed with transmitted light, indicated positive hemolytic ac-
tivity. The diameters of the zones of lysis and the colony were
measured with the aid of a computerized image analysis system
(Quantimet 500 Qwin; Leica, Cambridge, United Kingdom)
(18), and this ratio (equal to or larger than 1) was used as a
hemolytic index to represent the intensity of the hemolysin
production by different Candida species. The assay was con-
ducted in quadruplicate on two separate occasions for each
yeast isolate tested.
An additional experiment was performed to determine the
effect of the glucose supplement on the hemolysin production
by incubating a total of 12 hemolysin-positive yeasts in glucose-
free blood agar medium.
At 48 h postinoculation, two different types of hemolysis
could be observed circumscribing the yeast “colony” when
viewed with transmitted light (Fig. 1). The first was a totally
translucent ring identical to beta hemolysis produced by the
control strain of beta-hemolytic S. pyogenes, and the second
was a greenish-black halo comparable to alpha-hemolysis ob-
served with the control strain of S. sanguis. Hence, the terms
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alpha hemolysis and beta hemolysis were used as descriptive
terms to indicate incomplete and complete hemolysis, respec-
tively, associated with the Candida strains tested.
At 24 h postinoculation, only alpha hemolysis was observed
surrounding the inoculum sites with all strains of the Candida
spp. C. albicans, C. dubliniensis, C. kefyr, C. krusei, C. zeyla-
noides, C. glabrata, C. tropicalis, and C. lusitaniae. However,
after further incubation for 48 h the zone of hemolysis en-
larged and showed dual zones, i.e., an internal zone of beta
hemolysis surrounded by a peripheral zone of alpha hemolysis
(Fig. 1).
A total of nine Candida isolates belonging to C. famata,
C. guilliermondii, C. rugosa, and C. utilis exhibited only a zone
of alpha hemolysis despite prolonged inoculation (i.e., 72 h).
On the contrary, all tested isolates of C. parapsilosis and a
single isolate of C. peliculosa exhibited neither alpha nor beta
hemolysis despite 72 h of incubation (Table 1).
As opposed to the hemolytic patterns described above for
glucose-supplemented media, in experiments with glucose-free
sheep blood agar, all tested strains except those of C. parapsi-
losis and C. pelliculosa exhibited only alpha hemolysis. The last
two species produced neither alpha nor beta hemolysis.
In order to obtain quantitative data we attempted to mea-
sure the diameters of hemolytic zones relative to the inoculum
size using an image analysis system. However, clear-cut zones
were perceptible only in relation to beta-hemolytic activity.
The margins of alpha hemolysis were rather diffuse, and hence
the diameters of the latter zones were not accurately quanti-
fiable by either naked eye estimation or the image analysis
system.
The quantitative data indicated that the beta-hemolytic ac-
tivities of C. albicans, C. dubliniensis, C. kefyr, and C. tropicalis
were significantly higher than those of C. glabrata, C. krusei,
and C. lusitaniae (P , 0.05) (Fig. 2 and Table 1). Although
C. zeylanoides showed a much higher beta-hemolytic activity
than all other tested species, this result was equivocal as only a
single strain was examined (Table 1). Further, there was no
significant intraspecies differences in the beta-hemolytic activ-
ity among isolates belonging to C. albicans and C. glabrata.
Similar statistics could not be performed for the remaining spe-
cies due to the small number of isolates tested in each species.
The ability of pathogenic organisms to acquire elemental
iron has been shown to be of pivotal importance in their sur-
vival and ability to establish infection within the mammalian
host (3, 17). Since there is essentially no free iron in the human
host, most pathogens acquire this indirectly from commonly
available iron-containing compounds such as hemoglobin (2).
In order to do so, however, the pathogen should be equipped
with a mechanism that destroys the heme moiety and enables
it to extract the elemental iron. The enzymes mediating such
activity are broadly classified as hemolysins.
FIG. 1. Photographs depicting the hemolysis of sheep blood agar (supplemented with 3% glucose) induced by 14 different Candida species.
Panel a shows C. albicans (A), C. glabrata (B), C. parapsilosis (C), C. tropicalis (D), C. lusitaniae (E), C. zeylanoides (F), C. guilliermondii (G), and
C. famata (H). Panel b shows C. kefyr (A), C. pelliculosa (B), C. dubliniensis (C), C. utilis (D), C. parapsilosis (E), C. albicans (F), C. krusei (G),
and C. rugosa (H). A reference strain of C. albicans (ATCC90028) served as a positive control (I).
TABLE 1. Hemolytic activity of 14 different Candida species
isolated from human sourcesa
Species
No. of
isolates
tested
No. of isolates with hemolysin pattern
(hemolysis index,a mean 6 SD); groupb
Alpha Beta Gamma(none)
C. albicans 15 15 (1.718 6 0.164); A
C. glabrata 34 34 (1.376 6 0.052); B
C. dubliniensis 2 2 (1.695 6 0.077); A
C. kefyr 2 2 (1.705 6 0.120); A
C. lusitaniae 2 2 (1.285 6 0.163); B
C. krusei 4 4 (1.243 6 0.126); B
C. tropicalis 5 5 (1.654 6 0.094); A
C. zeylanoides 1 1 (2.237)
C. famata 3 3
C. guilliermondii 4 4
C. rugosa 1 1
C. utilis 1 1
C. parapsilosis 5 5
C. pelliculosa 1 1
a Hemolysis index: the diameter of the translucent radial zone of hemolysis
divided by the diameter of the colony size.
b Group A vs. group B: P , 0.05; statistics not performed for the single isolate
of C. zeylanoides; alpha hemolysis could not be quantified.
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A complement-mediated hemolysis induced by C. albicans
was reported by Manns et al. in 1994 (10), but a perusal of the
literature revealed no other reports on the hemolytic activity of
non-albicans species of Candida. In the present study, we con-
clusively demonstrate, both qualitatively and quantitatively the
hemolytic activity in a wide spectrum of Candida species be-
longing to 14 genera. The hemolysis so induced could be cat-
egorized according to the conventional microbiologic nomen-
clature as either complete (beta), incomplete (alpha), or no
hemolysis (gamma). Thus the terms alpha and beta hemolysis
used here to describe the different patterns of hemolysis in
Candida species can only be regarded as descriptive, since the
exact nature of these variants and the underlying mechanisms
are yet to be explored in full.
Of the tested Candida species, C. albicans, C. dubliniensis,
C. kefyr, C. krusei, C. zeylanoides, C. glabrata, C. tropicalis, and
C. lusitaniae demonstrated both alpha and beta hemolysis.
However, beta-hemolytic activity in these species was seen only
after 48 h followed by alpha hemolysis on 24 h of incubation,
whereas C. famata, C. guilliermondii, C. rugosa, and C. utilis
demonstrated only alpha-hemolytic activity despite prolonged
inoculation. These observations appear to suggest that alpha-
and beta-hemolytic activity may be a result of two or more
different hemolytic factors sequentially produced by the yeasts.
Thus, it is tempting to hypothesize that the erythrocytes are
destroyed by a two-stage mechanism. First would be a partial
destruction due to an alpha-hemolytic factor(s) generated by
the relatively young colonies of Candida. Thus, the metabolic
end products of the first stage may serve as a catalyst to induce
the secretion of a secondary hemolytic factor(s), beta hemoly-
sin, leading to complete destruction of hemoglobin. This hy-
pothesis accommodates our observations related to both the
alpha- and beta-hemolytic species of Candida, since some spe-
cies may be devoid of an enzymatic pathway necessary to
accomplish complete hemolytic activity.
The nature of the alpha-hemolytic factor(s) in microorgan-
isms is poorly understood. Hemolysins are known to be key
virulence factors contributing to the pathogenesis of common
bacterial infections due to staphylococci and streptococci. In a
recent study, Barnard and Stinson (1) demonstrated that the
alpha-hemolytic factor in Streptococcus gordonii is hydrogen
peroxide. Although C. albicans is capable of generating hydro-
gen peroxide (5), it is unclear whether the latter is responsible
for alpha hemolysis observed in the present study. Further
studies are needed to determine whether hydrogen peroxide
can also be produced by non-albicans Candida species which
exhibited alpha hemolysis and to examine the possible rela-
tionship, if any, between these two parameters.
Although Manns et al. (10) described a translucent complete
hemolytic ring induced by C. albicans, identical to the beta
hemolysis observed by us, yet again there is no biochemical
information on the beta-hemolytic factors released by Candida
species. It may be questioned whether the hemolytic activity
observed is true hemolysis or is a product of extracellular phos-
pholipases of Candida species. This is unlikely to be the case,
since only 26.4% of the 34 C. glabrata isolates used in the
present study were phospholipase positive when tested by an in
vitro egg yolk agar assay (unpublished data). Watanabe et al.
(15) have proposed that the beta hemolysin in C. albicans is
probably a cell wall mannoprotein. However, our observations
cast doubt on this hypothesis, since 6 of 14 Candida species we
tested were unable to produce beta hemolysis, although man-
noprotein is a universal component of the Candida cell wall.
One possible explanation for these disparate observations is
likely to be the variation in the cell wall mannoprotein content
among different Candida species. Furthermore, when the he-
molytic assay was performed using a glucose-free medium, only
alpha hemolysis was observed with the previously beta-hemo-
lytic Candida species. Thus, it appears that the absence of
glucose in the medium may have altered the sugar moiety of
the mannoprotein in some manner leading to the loss of beta-
hemolytic activity.
Although we have compared quantitatively the relative zone
sizes of beta hemolysis among Candida species and the data
showed that C. albicans, C. dubliniensis, C. kefyr, and C. tropi-
calis exhibited significantly higher beta-hemolytic activities
than other species, it should be borne in mind that there may
exist species-specific hemolysins that may vary in their molec-
ular size and thus affect the diffusion rate. Further studies
are warranted to evaluate these molecular differences, if any,
in Candida hemolysins.
C. albicans is a dimorphic yeast and exists in both the hyphal
and the blastoconidial phases, depending on the growth me-
dium and conditions. Previous workers have reported that he-
molysin is produced by C. albicans only when it is in the hyphal
form and not in the blastoconidial form (16). We doubt wheth-
er the hyphal form is a prerequisite for hemolysin production,
since both alpha and beta hemolysis were observed with all
strains of C. glabrata, considered a hyphae-negative species (7).
The modified plate assay described in the present report is
simple, reproducible, and sensitive and is a relatively fast
screening method for assessing the hemolytic activity of Can-
dida species. In clinical terms, it could be of interest to evaluate
the relationship between the virulence and the degree of he-
molysin production among pathogenic and commensal isolates
FIG. 2. Histogram depicting the beta-hemolytic activity of seven
different Candida species (the diameter of the translucent radial zone
of hemolysis divided by the diameter of the colony size). C. albicans
(Ca), C. dubliniensis (Cd), C. kefyr (Cky), and C. tropicalis (Ct) exhib-
ited a significantly higher beta-hemolytic activity than C. glabrata (Cg),
C. lusitaniae (Cl), and C. krusei (Ckr) (P , 0.05); bar represents 6 1
standard deviation. The number of strains in each species is indicated
in parenthesis. (A beta hemolysis positive species, C. zeylanoides, is not
shown here since only a single strain of this species was investigated.)
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of Candida using this method. Such studies are in progress in
our laboratories.
To conclude, the findings reported here for the first time
indicate that many Candida species exhibit various abilities to
produce one or more types of hemolysins, the nature of which
is ill understood at present. Of the common pathogenic spe-
cies, C. albicans and C. dubliniensis appear to be the most
prolific producers of hemolysins, in keeping with the foremost
position they occupy in the hierarchy of virulence amongst
Candida species. Further studies are urgently needed to inves-
tigate the nature of the hemolytic factors secreted by Candida,
their utility in diagnostic terms and, last but not the least, their
putative effects in the human host.
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